Anesthetic Management of Pediatric Pulmonary Arterial Hypertension

Volume: 24 Number: 2 March 5, 2015
Mediha Türktan , Zehra Hatipoğlu
EN TR

Anesthetic Management of Pediatric Pulmonary Arterial Hypertension

Abstract

Pulmonary arterial hypertension is the most important cause of morbidity and mortality associated with congenital heart disease. Patients in this group have a greater peroperative cardiovascular risks including cardiac arrest, pulmonary hypertensive crisis and death compared the normal population. The main purpose of anesthesia is to avoid increased pulmonary vascular resistance and myocardial depression.

Keywords

Pulmonary arterial hypertension,congenital heart disease, anesthesia

References

  1. Friesen RH, Williams GD. Anesthetic Management of Children with Pulmonary Arterial Hypertension. Paediatr Anaesth. 2008;18:208-16.
  2. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43:5–12.
  3. Kanbay A, Büyükoğlan H, Oymak FS, Demir R. Pulmoner hipertansiyon ve yeni sınıflama. Yeni Tıp Dergisi. 2010;27:208-12.
  4. Tuncel Z, Kuddisioğlu ŞT, Aykaç Z. Pediyatrik konjenital kalp hastalıklarına bağlı pulmoner hipertansiyonda anestezik yaklaşım. GKDA Dergisi. 2013;19:2-9.
  5. Taylor CJ, Derrick G, McEwan A, Haworth SG, Sury MR. Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. Br J Anaesth. 2007;98:657–61. 6. Carmosino MJ, Friesen RH, Doran A, Ivy DD. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg. 2007;104:521-7.
  6. Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon MD. Impact of pulmonary hypertension on the outcomes of noncardiac surgery. J Am Coll Cardiol. 2005;45:1691-9.
  7. Friesen RH, Alswang M. Changes in carbon dioxide tension and oxygen saturation during deep sedation for paediatric cardiac catheterization. Pediatr Anesth. 1996;6:15-20.
  8. Williams GD, Maan H, Ramamoorthy C, Kamra K, Bratton SL, Bair E, et al. Perioperative complications in children with pulmonary hypertension undergoing general anesthesia with ketamine. Pediatric Anesthesia. 2010;20: 28–37.
  9. Abman SH. Neonatal pulmonary hypertension: a physiologic approach to treatment. Pediatr Pulmonol Suppl. 2004;26:127-8.
  10. Foubert L, Fleming B, Jonas M, Oduro A, Borland C, Higenbottam T. Safety guidelines for use of nitric oxide. Lancet. 1992;339:1615-6.
AMA
1.Türktan M, Hatipoğlu Z. Anesthetic Management of Pediatric Pulmonary Arterial Hypertension. Arşiv Kaynak Tarama Dergisi. 2015;24(2):149-158. doi:10.17827/aktd.05308